|
|||||
|
|
Limits of traditional evidence-based medicine methodologies exemplified by the novel era in psoriatic arthritis drug development |
|
| Authors: | Emmerik F. Leijten Timothy R. Radstake Iain B. McInnes Johannes W. Jacobs |
| Affiliation: | 1. Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands;2. Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands;3. Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK |
| Abstract: | |
| Keywords: | Biomarker evidence-based medicine psoriatic arthritis trial design |